Helen Le Butt,Phillip Matthew Ireland,Petra Claire Farquar Oyston
申请号：
US13264175
公开号：
US20120107360A1
申请日:
2010.04.14
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to a mutated Francisella bacterium, wherein the ggt gene is silenced or deleted pharmaceutical compositions comprising the same, in particular, vaccine compositions, and use of the bacterium and compositions for treatment and/or prophylaxis, and in particular, the treatment or prophylaxis of tularemia.
